FLAM
VRTX icon

First Light Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

First Light Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-22,828
Closed -$5.43M – 69
2020
Q1 		$5.43M Sell
22,828
-3,689
-14% -$846K 0.93% 29
2019
Q4 		$5.81M Sell
26,517
-98
-0.4% -$19.8K 0.74% 32
2019
Q3 		$4.51M Sell
26,615
-263
-1% -$46.5K 0.68% 37
2019
Q2 		$4.93M Buy
26,878
+119
+0.4% +$20.8K 0.68% 39
2019
Q1 		$4.92M Buy
26,759
+2,144
+9% +$396K 0.64% 38
2018
Q4 		$4.08M Sell
24,615
-172
-0.7% -$29.8K 0.65% 36
2018
Q3 		$4.78M Sell
24,787
-187
-0.7% -$33.3K 0.77% 29
2018
Q2 		$4.25M Buy
24,974
+1,545
+7% +$239K 0.66% 32
2018
Q1 		$3.82M Buy
23,429
+372
+2% +$60.8K 0.84% 31
2017
Q4 		$3.46M Sell
23,057
-364
-2% -$53.9K 0.95% 31
2017
Q3 		$3.56M Buy
23,421
+302
+1% +$45.5K 1.13% 29
2017
Q2 		$2.98M Sell
23,119
-6
-0% -$722 1% 31
2017
Q1 		$2.53M Sell
23,125
-100
-0.4% -$8.8K 0.97% 31
2016
Q4 		$1.71M Sell
23,225
-85
-0.4% -$6.92K 0.75% 35
2016
Q3 		$2.03M Sell
23,310
-525
-2% -$49.6K 0.88% 38
2016
Q2 		$2.05M Sell
23,835
-441
-2% -$38.1K 0.95% 36
2016
Q1 		$1.93M Sell
24,276
-44
-0.2% -$3.98K 0.97% 38
2015
Q4 		$3.06M Sell
24,320
-323
-1% -$39K 1.28% 31
2015
Q3 		$2.57M Buy
24,643
+3,545
+17% +$455K 1.27% 31
2015
Q2 		$2.6M Buy
21,098
+1,733
+9% +$218K 1.23% 30
2015
Q1 		$2.28M Buy
19,365
+1,774
+10% +$213K 1.17% 32
2014
Q4 		$2.09M Buy
17,591
+1,306
+8% +$147K 1.18% 29
2014
Q3 		$1.83M Buy
16,285
+436
+3% +$41.5K 1.25% 27
2014
Q2 		$1.5M Buy
15,849
+859
+6% +$60.2K 1.01% 37
2014
Q1 		$1.06M Buy
14,990
+1,971
+15% +$156K 0.75% 39
2013
Q4 		$967K Buy
+13,019
New +$907K 0.82% 36

Other funds holding VRTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

First Light Asset Management's VRTX Position: Q2 2020 in Review

First Light Asset Management sold out of Vertex Pharmaceuticals (VRTX) in Q2 2020, closing a stake of 22,828 shares — an estimated $5.43M sold.

First Light Asset Management first reported a position in VRTX in Q4 2013 and held it in 26 quarters. The position peaked at $5.81M in Q4 2019. 964 funds tracked by Wall St. Rank hold VRTX as of Q2 2020.

  • First Light Asset Management reported no remaining Vertex Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • First Light Asset Management sold 22,828 Vertex Pharmaceuticals shares in Q2 2020, an estimated $5.43M.
  • First Light Asset Management first reported a position in Vertex Pharmaceuticals in Q4 2013 and held it in 26 quarters.
  • First Light Asset Management's Vertex Pharmaceuticals position peaked at $5.81M in Q4 2019.
  • 964 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2020.

Based on First Light Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.